Alercell Launches "Lena Molecular Diagnostic Leukemia Platform"
/PRNewswire/ -- ALERCELL, INC. announced today that it has introduced a molecular Leukemia diagnostic platform. LENA Molecular Dx Leukemia Platform is a core...
Stay updated with breaking news from Alercell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- ALERCELL, INC. announced today that it has introduced a molecular Leukemia diagnostic platform. LENA Molecular Dx Leukemia Platform is a core...
/PRNewswire/ -- Alercell today announced the opening of Alercell UK LTD. with principal office in central London (UK). Alercell will develop in London its R&D...
/PRNewswire/ -- ALERCELL, INC. announced today that it has launched a new website LENA DIAGNOSTICS ©" www.lenadx.com. The new site is dedicated only to...
/PRNewswire/ -- ALERCELL, INC. announced today that it has introduced a new Research Use Only (RUO) LENA Q51® Leukemia diagnostic test for commercial sale....
BOZEMAN, MT, Dec. 28, 2022 (GLOBE NEWSWIRE) -- Alercell is all set to launch LENA Q51(R) in January 2023. A leukemia diagnostic test based on sequencing...